MedPath
FDA Product

Tizanidine

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Tizanidine

50436-6756

Regulatory Information

50436-6756

ANDA076286

C73584

June 20, 2017

USA

These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996

HUMAN PRESCRIPTION DRUG LABEL

10

Company Information

Unit Dose Services

831995316

Active Ingredients

anhydrous lactose

Code: 3SY5LH9PMK

Class Code: IACT

TIZANIDINE HYDROCHLORIDE

Quantity: 4 mg in 1 1

Code: B53E3NMY5C

Class Code: ACTIM

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

silicon dioxide

Code: ETJ7Z6XBU4

Class Code: IACT

stearic acid

Code: 4ELV7Z65AP

Class Code: IACT

Active Moieties

TIZANIDINE

Code: 6AI06C00GW

© Copyright 2025. All Rights Reserved by MedPath